RT Journal Article
SR Electronic
T1 Common abnormality of gray matter integrity in substance use disorder and obsessive-compulsive disorder: A comparative voxel-based meta-analysis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.03.20187229
DO 10.1101/2020.09.03.20187229
A1 Benjamin Klugah-Brown
A1 Chenyang Jiang
A1 Elijah Agoalikum
A1 Xinqi Zhou
A1 Liye Zou
A1 Qian Yu
A1 Benjamin Becker
A1 Bharat Biswal
YR 2020
UL http://medrxiv.org/content/early/2020/09/03/2020.09.03.20187229.abstract
AB Aim To determine robust transdiagnostic brain structural markers for compulsivity by capitalizing on the increasing number of case-control studies examining gray matter alterations in substance use disorders (SUD) and obsessive-compulsive disorder (OCD).Design Pre-registered voxel-based meta-analysis of grey matter volume (GMV) changes through seed-based d Mapping (SDM), follow-up functional, and network-level characterization of the identified transdiagnostic regions by means of co-activation and Granger Causality (GCA) analysis.Participants Literature search resulted in 31 original VBM studies comparing SUD (n = 1191, mean-age = 40.03, SD = 10.87) and 30 original studies comparing OCD (n = 1293, mean-age = 29.18, SD = 10.34) patients with healthy controls (SUD: n = 1585, mean-age = 42.63, SD = 14.27, OCD: n = 1374, mean-age = 28.97, SD = 9.96).Measurements Voxel-based meta-analysis within the individual disorders as well as conjunction analysis were employed to reveal common GMV alterations between SUDs and OCD. Meta-analytic coordinates and signed brain volumetric maps determining directed (reduced or increased) brain volumetric alterations between the disorder groups and controls served as the primary outcome. Meta-analytic results employed statistical significance thresholding (FWE< 0.05).Findings Separate meta-analysis demonstrated that SUD (cocaine, alcohol, and nicotine) as well as OCD patients exhibited widespread GMV reductions in frontocortical regions including prefrontal, cingulate, and insular regions. Conjunction analysis revealed that the left inferior frontal gyrus (IFG) consistently exhibited decreased GMV across all disorders. Functional characterization suggests that the IFG represents a core hub in the cognitive control network and exhibits bidirectional (Granger) causal interactions with the striatum. Only OCD showed increased GMV in the dorsal striatum with higher changes being associated with more severe OCD symptomatology.Conclusions Findings demonstrate robustly decreased GMV across the disorders in the left IFG, suggesting a transdiagnostic brain structural marker. The functional characterization as a key hub in the cognitive control network and casual interactions with the striatum suggest that deficits in inhibitory control mechanisms may promote compulsivity and loss of control that characterize both disorders.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Key Research and Development Program of China (Grant No. 2018YFA0701400), National Natural Science Foundation of China (NSFC, No 91632117), and Science, Innovation and Technology Department of the Sichuan Province (2018JY0001).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Laboratory for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology of China, No.2006, Xiyuan Avenue, West Hi-Tech Zone, Chengdu, Sichuan 611731, ChinaAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data associated with this work shall be provided upon request